Stay updated with breaking news from Liminal Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
These materials are important and require your immediate attention. If you are a shareholder of Liminal BioSciences Inc. and have any questions regarding the information contained in...
/PRNewswire/ - Liminal BioSciences Inc. (NASDAQ: LMNL) ("Liminal BioSciences" or the "Company"), announced today that the Ontario Superior Court of Justice...
These materials are important and require your immediate attention. They require shareholders of Liminal BioSciences Inc. to make important decisions. If you are in doubt about how to... -Today at 05:36 pm- MarketScreener
Provided R&D update on GPCR-targeted pipeline, including nomination of lead candidate for OXER1 antagonist programClosed June 30, 2023 with over CAD 19 million cash on hand, expecting to provide...